-
EP4134367
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4134367
| EP4134367 - PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 22.12.2023 Database last updated on 28.06.2024 | |
| Former | Request for examination was made Status updated on 18.08.2023 | ||
| Former | The application has been published Status updated on 13.01.2023 | Most recent event Tooltip | 22.12.2023 | Application deemed to be withdrawn | published on 24.01.2024 [2024/04] | Applicant(s) | For all designated states CHUGAI SEIYAKU KABUSHIKI KAISHA 5-1, 5-chome Ukima Kita-ku Tokyo 115-8543 / JP | [2023/07] | Inventor(s) | 01 /
YOSHINO, Hitoshi Gotemba-shi Shizuoka / JP | 02 /
TSUCHIYA, Satoshi Gotemba-shi Shizuoka / JP | 03 /
MATSUO, Atsushi Gotemba-shi Shizuoka / JP | 04 /
SATO, Tsutomu Gotemba-shi Shizuoka / JP | 05 /
NISHIMOTO, Masahiro Gotemba-shi Shizuoka / JP | 06 /
OGURI, Kyoko Gotemba-shi Shizuoka / JP | 07 /
OGAWA, Hiroko Gotemba-shi Shizuoka / JP | 08 /
NISHIMURA, Yoshikazu Gotemba-shi Shizuoka / JP | 09 /
FURUTA, Yoshiyuki Gotemba-shi Shizuoka / JP | 10 /
KASHIWAGI, Hirotaka Gotemba-shi Shizuoka / JP | 11 /
HORI, Nobuyuki Gotemba-shi Shizuoka / JP | 12 /
KAMON, Takuma Gotemba-shi Shizuoka / JP | 13 /
SHIRAISHI, Takuya Gotemba-shi Shizuoka / JP | 14 /
YOSHIDA, Shoshin Gotemba-shi Shizuoka / JP | 15 /
KAWAI, Takahiro Gotemba-shi Shizuoka / JP | 16 /
TANIDA, Satoshi Gotemba-shi Shizuoka / JP | 17 /
AOKI, Masahide Gotemba-shi Shizuoka / JP | [2023/07] | Representative(s) | Ingham, Stephen Howard Eli Lilly and Company Limited 8 Arlington Square West Downshire Way Bracknell, Berkshire RG12 1PU / GB | [2023/07] | Application number, filing date | 22180270.5 | 26.09.2017 | [2023/07] | Priority number, date | JP20160187605 | 26.09.2016 Original published format: JP 2016187605 | [2023/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4134367 | Date: | 15.02.2023 | Language: | EN | [2023/07] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 23.12.2022 | Classification | IPC: | C07D471/04, A61K31/437, A61K31/444, A61K31/4709, A61K31/4725, A61K31/496, A61K31/506, A61K31/5377, A61K31/5386, A61P1/16, A61P3/04, A61P3/06, A61P3/10, A61P9/10, A61P25/16, A61P25/28, C07D519/00 | [2023/07] | CPC: |
C07D471/04 (EP,EA,IL,KR,US);
A61K31/437 (EP,EA,IL,KR,US);
A61K31/444 (EP,EA,IL,US);
A61K31/4709 (EP,EA,IL,US);
A61K31/4725 (EP,EA,IL,US);
A61K31/496 (EP,EA,IL,US);
A61K31/506 (EP,EA,IL,US);
A61K31/5377 (EP,EA,IL,KR,US);
A61K31/5386 (EP,EA,IL,US);
A61P1/16 (EP,EA,IL,KR,US);
A61P25/16 (EP,EA,IL,KR,US);
A61P25/28 (EP,EA,IL,KR,US);
A61P3/04 (EP,EA,IL,KR,US);
A61P3/06 (EP,EA,IL,KR,US);
A61P3/10 (EP,EA,IL,KR,US);
A61P9/10 (EP,EA,IL,KR,US);
C07D413/14 (EP);
C07D519/00 (EP,EA,IL,US);
Y02A50/30 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/38] |
| Former [2023/07] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 16.08.2023 | ME | 16.08.2023 | Validation states | MA | 16.08.2023 | MD | 16.08.2023 | Title | German: | PYRAZOLOPYRIDINDERIVAT MIT GLP-1-REZEPTOR-AGONISTENWIRKUNG | [2023/07] | English: | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | [2023/07] | French: | DÉRIVÉ DE PYRAZOLOPYRIDINE AYANT UN EFFET AGONISTE DU RÉCEPTEUR GLP-1 | [2023/07] | Examination procedure | 16.08.2023 | Examination requested [2023/38] | 16.08.2023 | Date on which the examining division has become responsible | 17.08.2023 | Application deemed to be withdrawn, date of legal effect [2024/04] | 06.09.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2024/04] | Parent application(s) Tooltip | EP17853220.6 / EP3517538 | Fees paid | Renewal fee | 21.10.2022 | Renewal fee patent year 03 | 21.10.2022 | Renewal fee patent year 04 | 21.10.2022 | Renewal fee patent year 05 | 21.10.2022 | Renewal fee patent year 06 | 02.10.2023 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US2015087640 (MJALLI ADNAN M M [US], et al); | [A]WO2016038045 (HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT GMBH [DE], et al) | by applicant | WO9950262 | US5998438 | WO2006048727 | WO2009111700 | WO2009152133 | WO2010114824 | WO2012080471 | WO2013010904 | CN103086955 | WO2014201206 | WO2016038045 |